| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090944576 |
| P356 | DOI | 10.1007/S11064-017-2358-X |
| P698 | PubMed publication ID | 28770436 |
| P50 | author | Iris Speigel | Q83420073 |
| P2093 | author name string | Paul S García | |
| William R Tyor | |||
| Vincent T Ciavatta | |||
| Edyta K Bichler | |||
| Courtney C Elder | |||
| Shavonne L Teng | |||
| P2860 | cites work | Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 |
| Culturing hippocampal neurons | Q29615174 | ||
| Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors | Q29616809 | ||
| Evidence-based treatment for HIV-associated dementia and cognitive impairment: why so little? | Q33280776 | ||
| Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort | Q33813911 | ||
| Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport | Q33870898 | ||
| Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells | Q34219621 | ||
| HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies | Q34599414 | ||
| Successful aging and the epidemiology of HIV. | Q35137873 | ||
| Practical guidelines to interpret plasma concentrations of antiretroviral drugs | Q35929973 | ||
| Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis | Q35968510 | ||
| HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells | Q36277573 | ||
| Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons | Q36350473 | ||
| Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz | Q36406259 | ||
| Antiretroviral neurotoxicity | Q36635673 | ||
| Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose | Q36729929 | ||
| Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy | Q37019423 | ||
| Synaptogenesis in purified cortical subplate neurons | Q37250208 | ||
| Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy | Q37302877 | ||
| Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system | Q37592018 | ||
| A review of the toxicity of HIV medications | Q37633495 | ||
| The brain and HAART: collaborative and combative connections | Q38256083 | ||
| Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines | Q38880828 | ||
| Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz | Q38996720 | ||
| Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor | Q39396414 | ||
| CH05-10, a novel indinavir analog, is a broad-spectrum antitumor agent that induces cell cycle arrest, apoptosis, endoplasmic reticulum stress and autophagy. | Q39644230 | ||
| Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line | Q40198849 | ||
| Neuropathies in HIV infection. | Q41056082 | ||
| Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations | Q41208022 | ||
| Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model. | Q42243855 | ||
| Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells | Q43011656 | ||
| Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity | Q45417353 | ||
| Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. | Q46111007 | ||
| Highly active antiretroviral therapy and human immunodeficiency virus encephalitis | Q46456152 | ||
| Antiretroviral drugs and the central nervous system | Q48350664 | ||
| Intrinsic excitability of CA1 pyramidal neurones from the rat dorsal and ventral hippocampus | Q48372373 | ||
| Measurement of mitochondrial oxygen consumption rates in mouse primary neurons and astrocytes | Q48488075 | ||
| Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort | Q79861399 | ||
| The relationship of CPE to HIV dementia: slain by an ugly fact? | Q88035349 | ||
| P433 | issue | 11 | |
| P921 | main subject | efavirenz | Q422645 |
| neurotoxicity | Q3338704 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 3220-3232 | |
| P577 | publication date | 2017-08-02 | |
| P1433 | published in | Neurochemical Research | Q15716728 |
| P1476 | title | In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals | |
| P478 | volume | 42 |
| Q57310566 | Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume |
| Q90071250 | Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches |
| Q92158622 | HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders |
| Q93168370 | Interactive effects of HIV and ageing on neural oscillations: independence from neuropsychological performance |
| Q90108881 | Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy |
Search more.